ArticleOncology reports2022

Administration of 4‑hexylresorcinol increases p53‑mediated transcriptional activity in oral cancer cells with the p53 mutation.

Yei-Jin Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.